PB1840: OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER TREATMENT WITH VENETOCLAX/HYPOMETHYLATING AGENTS

• Sabine Kayser,
• Khaled Sanber,
• Giovanni Marconi,
• Agnese Mattei,
• Marlise Luskin,
• Amar Kelkar,
• Marco Cerrano,
• Chiara Sartor,
• Fabio Giglio,
• Marta Riva,
• Lorenzo Rizzo,
• Francesco Saraceni,
• Selene Guerzoni,
• Federica Lessi,
• Erika Borlenghi,
• Alexander Perl,
• Mark J Levis,
• Cristina Papayannidis,
• Tania Jain,
• Richard Schlenk

Affiliations

Sabine Kayser

1 Institute ofTransfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany

Khaled Sanber

3 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, United States

Giovanni Marconi

4 Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Agnese Mattei

4 Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Marlise Luskin

5 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States

Amar Kelkar

5 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States

Marco Cerrano

6 Deptartment of Oncology, Division of Hematology, Presidio Molinette, Torino, Italy

Chiara Sartor

7 Istituto di Ematologia “Seràgnoli, Bologna, Italy

Fabio Giglio

8 Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

Marta Riva

10 S.C. EMATOLOGIA Dipartimento di Ematologia, Oncologia e Medicina Molecolare Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Lorenzo Rizzo

10 S.C. EMATOLOGIA Dipartimento di Ematologia, Oncologia e Medicina Molecolare Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Francesco Saraceni

11 Department of Hematology and Bone Marrow Transplantation, Ospedali Riuniti, Ancona, Italy

Selene Guerzoni

11 Department of Hematology and Bone Marrow Transplantation, Ospedali Riuniti, Ancona, Italy

Federica Lessi

12 Ematologia Azienda Ospedale Università Padova, Padova, Italy

Erika Borlenghi

13 Department of Hematology, ASST Spedali Civili, Brescia, Italy

Alexander Perl

14 Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Pennsylvania, United States

Mark J Levis

3 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, United States

Cristina Papayannidis

7 Istituto di Ematologia “Seràgnoli, Bologna, Italy

Tania Jain

16 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, bal

Richard Schlenk

2 NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany